Valuation GSK plc Xetra

Stocks

Market Closed - Xetra 16:35:48 30/09/2026 BST			After hours 19:20:21
21.39 ^EUR	-1.20%		21.40	+0.07%

04:20pm	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MT
01:20pm	Major drugmakers turn to China for licensing deals	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	74,370	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	1.6%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	95,612	92,887	90,066
Change	-	-24.65%	-1.89%	-8.24%	28.83%	9.08%	-2.85%	-3.04%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	14.4x	11.9x	11x
PBR	5.34x	5.47x	4.4x	4.02x	4.51x	4.59x	4.04x	3.58x
PEG	-	0x	-0.2x	-0.4x	0x	-1.66x	0.6x	1.34x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.19x	2.1x	2.03x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.82x	2.62x	2.46x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.33x	7.57x	7.09x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.27x	8.41x	7.81x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.1x	16.2x	13.5x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.85%	6.16%	7.41%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7494	0.7843
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.75%	4.04%	4.23%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.289	1.566	1.694
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	54%	47.9%	46.3%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,920	35,498	36,615
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,473	12,275	12,711
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,310	11,046	11,531
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,191	6,209	6,755
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	21,242	18,517	15,696
Reference price ²	20.08	14.38	14.50	13.46	18.24	18.56	18.56	18.56
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	09/02/22	01/02/23	31/01/24	05/02/25	04/02/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	29.76x	6.61x	18.5x	2%	645B
ABBVIE INC.	33.32x	7.79x	16.11x	2.63%	465B
MERCK & CO., INC.	108.6x	6.05x	25.67x	2.29%	368B
ROCHE HOLDING AG	19.01x	4.64x	11.49x	2.87%	335B
NOVARTIS AG	20.51x	5.32x	13.17x	3.01%	275B
ASTRAZENECA PLC	20.92x	4.34x	12.36x	2.04%	255B
AMGEN INC.	26.76x	6.95x	12.37x	2.38%	229B
GILEAD SCIENCES, INC.	-45.76x	6.66x	26x	2.18%	188B
Average	27.42x	6.73x	17.83x	2.22%	423.98B
Weighted average by Cap.	32.80x	7.85x	19.23x	1.9%